K. Charles
Oncology · The Lancet Oncology · 2005–2014
A researcher in the Science corpus: 3 papers; trusts 1 researcher and is trusted by 9 researchers here, as inferred from the citation graph.
Subfields
- Oncology — 31 citations into it; #233 of 1,698 by trust here, #620 by citations
Whom K. Charles trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts K. Charles overall
Papers from K. Charles's perspective
Ordered by how strongly the researchers K. Charles trusts endorse each paper. Same corpus, a different order for every researcher.
- Hallmarks of cancer: the next generation. (Cell)
- The hallmarks of cancer (RNA Biology)
- Ratio of neutrophil to lymphocyte counts--rapid and simple parameter of systemic inflammation and stress in critically ill. (Bratislava Medical Journal)
- Neutrophil‐lymphocyte ratio as a prognostic factor in colorectal cancer (Journal of Surgical Oncology)
- Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. (Future Oncology)
- Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. (Cell)
- Microenvironmental regulation of metastasis (Nature Reviews. Cancer)
- Altered macrophage differentiation and immune dysfunction in tumor development. (Journal of Clinical Investigation)
- Inflammation and cancer (Nature)
- gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. (Cancer Cell)
Their papers
- Cancer-related inflammation and treatment effectiveness. (2014) — 1,994 citations
- The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. (2013) — 1,495 citations
- Smoldering and polarized inflammation in the initiation and promotion of malignant disease. (2005) — 1,844 citations